TRXADE HEALTH INC (MEDS) Stock Price, Quote, News and Overview
NASDAQ:MEDS - Nasdaq - US89846A4058 - Common Stock - Currency: USD
MEDS Quote, Performance and Key Statistics
TRXADE HEALTH INC
NASDAQ:MEDS (9/20/2024, 8:07:08 PM)
After market: 7.591 +0 (+0.01%)7.59
+0.35 (+4.83%)
The current stock price of MEDS is 7.59 USD. In the past month the price decreased by -8.22%. In the past year, price increased by 12.78%.
MEDS Latest News, Press Releases and Analysis
TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.
TRxADE Health (NASDAQ: MEDS), a parent company of pharmaceutical business-to-business (“B2B”) exchange platform, and Scienture Inc., a wholly owned subsidiary of TRxADE, have announced a name change. According to the announcement, TRxADE is changing its name to Scienture Holdings Inc. The change is effective beginning Sept. 23, 2024; company stock will also begin trading on the NASDAQ […]
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly...
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC’s Executive Leadership Team
TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly...
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in...
MEDS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 36.12 | 36.65B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.42 | 10.33B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.64B | ||
| CERT | CERTARA INC | 34.36 | 2.16B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 15.16 | 1.85B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.76B | ||
| SDGR | SCHRODINGER INC | N/A | 1.75B | ||
| PHR | PHREESIA INC | N/A | 1.57B | ||
| EVH | EVOLENT HEALTH INC - A | 10.97 | 1.16B | ||
| HSTM | HEALTHSTREAM INC | 49.52 | 978.90M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 962.61M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 13.59 | 716.01M |
Related stock screener links
About MEDS
Company Profile
TRxADE HEALTH, Inc. is a health services information technology company, which focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. The company is headquartered in Lutz, Florida and currently employs 8 full-time employees. The company went IPO on 2020-02-18. The firm is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
Company Info
TRXADE HEALTH INC
2420 Brunello Trace
Lutz FLORIDA 34639 US
CEO: Suren Ajjarapu
Employees: 8
Company Website: https://www.trxadehealth.com/
Phone: 18002610281
MEDS FAQ
What is the stock price of MEDS?
The current stock price of MEDS is 7.59 USD.
What is the symbol for TRXADE HEALTH INC stock?
The exchange symbol of TRXADE HEALTH INC is MEDS and it is listed on the Nasdaq exchange.
On which exchange is MEDS stock listed?
MEDS stock is listed on the Nasdaq exchange.
Is MEDS a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for MEDS, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of MEDS.
Does MEDS stock pay dividends?
MEDS has a dividend yield of 125.16%. The yearly dividend amount is currently 0.
What is the Price/Earnings (PE) ratio of MEDS?
MEDS does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.29).
MEDS Technical Analysis
MEDS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MEDS. While MEDS seems to be doing ok healthwise, there are quite some concerns on its profitability.
MEDS Financial Highlights
Over the last trailing twelve months MEDS reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS decreased by 63.73% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 94.17% | ||
| ROA | 28.09% | ||
| ROE | 35.39% | ||
| Debt/Equity | 0 |
MEDS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to MEDS. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 4.1% for MEDS